Sun Pharmaceutical Industries responded to stock exchange inquiries regarding media speculation about a potential $12 billion Organon deal, stating no ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE